The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Jin David | Chief Financial Officer | Grant(A) | 400K | — | $0 |
| Apr 1, 2026 | Jin David | Chief Financial Officer | Grant(A) | 3K | $2.18 | $6K |
| Mar 18, 2026 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Grant(A) | 475K | — | $0 |
| Mar 18, 2026 | Weiss Michael S | Executive Vice Chairman, Director | Grant(A) | 475K | — | $0 |
| Jan 1, 2026 | Lobell J Jay | Director | Grant(A) | 27K | — | $0 |
| Jan 1, 2026 | Hoenlein Malcolm | Director | Grant(A) | 27K | — | $0 |
| Jan 1, 2026 | Harvey Jimmie | Director | Grant(A) | 27K | — | $0 |
| Jan 1, 2026 | Klein Dov | Director | Grant(A) | 27K | — | $0 |
| Jan 1, 2026 | Lorenz Kevin | Director | Grant(A) | 27K | — | $0 |
| Oct 1, 2025 | Jin David | Chief Financial Officer | Grant(A) | 3K | $1.31 | $4K |
| Apr 1, 2025 | Jin David | Chief Financial Officer | Grant(A) | 5K | $1.22 | $6K |
| Jan 1, 2025 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Grant(A) | 454K | — | $0 |
| Jan 1, 2025 | Weiss Michael S | Executive Vice Chairman, Director | Grant(A) | 454K | — | $0 |
| Jan 1, 2025 | Hoenlein Malcolm | Director | Grant(A) | 49K | — | $0 |
| Jan 1, 2025 | Lorenz Kevin | Director | Grant(A) | 49K | — | $0 |
| Jan 1, 2025 | Harvey Jimmie | Director | Grant(A) | 49K | — | $0 |
| Jan 1, 2025 | Lu Lucy | Director | Grant(A) | 49K | — | $0 |
| Jan 1, 2025 | Klein Dov | Director | Grant(A) | 49K | — | $0 |
| Jan 1, 2025 | Lobell J Jay | Director | Grant(A) | 49K | — | $0 |
| Dec 19, 2024 | Jin David | Chief Financial Officer | Grant(A) | 1.0M | — | $0 |
| Oct 1, 2024 | Jin David | Chief Financial Officer | Grant(A) | 3K | $1.23 | $3K |
| Sep 23, 2024 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Buy(P) | 763K | $1.84 | $1.4M |
| Sep 23, 2024 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Buy(P) | 763K | $0.13 | $99K |
| Jul 11, 2024 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 5K | $7.48 | $37K |
| Jul 10, 2024 | Jin David | Chief Financial Officer | Buy(P) | 500 | $7.50 | $4K |
| Jul 9, 2024 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 5K | $7.39 | $37K |
| Jul 8, 2024 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 5K | $7.35 | $37K |
| Jun 28, 2024 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 20K | $1.64 | $33K |
| May 20, 2024 | Klein Dov | Director | Sell(S) | 10K | $1.89 | $19K |
| May 16, 2024 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 10K | $1.76 | $18K |
| Apr 1, 2024 | Jin David | Chief Financial Officer | Grant(A) | 2K | $1.70 | $4K |
| Jan 5, 2024 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 50K | $2.38 | $119K |
| Jan 1, 2024 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Grant(A) | 216K | — | $0 |
| Jan 1, 2024 | Rowinsky Eric K | Director | Grant(A) | 7K | — | $0 |
| Jan 1, 2024 | Weiss Michael S | See Remarks, Director, 10% Owner | Grant(A) | 216K | — | $0 |
| Jan 1, 2024 | Harvey Jimmie | Director | Grant(A) | 7K | — | $0 |
| Jan 1, 2024 | Hoenlein Malcolm | Director | Grant(A) | 3K | — | $0 |
| Jan 1, 2024 | Klein Dov | Director | Grant(A) | 7K | — | $0 |
| Jan 1, 2024 | Lobell J Jay | Director | Grant(A) | 7K | — | $0 |
| Jan 1, 2024 | Lorenz Kevin | Director | Grant(A) | 3K | — | $0 |
| Jan 1, 2024 | Lu Lucy | Director | Grant(A) | 3K | — | $0 |
| Dec 20, 2023 | Jin David | Chief Financial Officer | Grant(A) | 140K | — | $0 |
| Nov 14, 2023 | Weiss Michael S | See Remarks, Director | Buy(P) | 147K | $1.70 | $250K |
| Nov 14, 2023 | Weiss Michael S | See Remarks, Director | Buy(P) | 147K | — | $0 |
| Nov 14, 2023 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 1.6M | $1.70 | $2.7M |
| Nov 14, 2023 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 1.6M | — | $0 |
| Sep 26, 2023 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 100K | $0.28 | $28K |
| Aug 18, 2023 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 10K | $9.34 | $93K |
| Aug 17, 2023 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 10K | $11.75 | $118K |
| Feb 10, 2023 | Jin David | Chief Financial Officer | Buy(P) | 36K | $0.84 | $30K |
| Feb 10, 2023 | Lobell J Jay | Director | Buy(P) | 299K | $0.84 | $251K |
| Feb 10, 2023 | Lu Lucy | Director | Buy(P) | 12K | $0.84 | $10K |
| Feb 10, 2023 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Buy(P) | 2.4M | $0.84 | $2.0M |
| Feb 10, 2023 | Rowinsky Eric K | Director | Buy(P) | 12K | $0.84 | $10K |
| Feb 10, 2023 | Weiss Michael S | See Remarks, Director, 10% Owner | Buy(P) | 1.2M | $0.84 | $1.0M |
| Jan 1, 2023 | Harvey Jimmie | Director | Grant(A) | 100K | — | $0 |
| Jan 1, 2023 | Hoenlein Malcolm | Director | Grant(A) | 50K | — | $0 |
| Jan 1, 2023 | Klein Dov | Director | Grant(A) | 100K | — | $0 |
| Jan 1, 2023 | Lobell J Jay | Director | Grant(A) | 100K | — | $0 |
| Jan 1, 2023 | Lorenz Kevin | Director | Grant(A) | 50K | — | $0 |
| Jan 1, 2023 | Rowinsky Eric K | Director | Grant(A) | 100K | — | $0 |
| Jan 1, 2023 | Weiss Michael S | See Remarks, Director, 10% Owner | Grant(A) | 1.2M | — | $0 |
| Jan 1, 2023 | Lu Lucy | Director | Grant(A) | 50K | — | $0 |
| Jan 1, 2023 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Grant(A) | 1.2M | — | $0 |
| Dec 16, 2022 | Lu Lucy | Director | Grant(A) | 30K | — | $0 |
| Dec 1, 2022 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Buy(P) | 100K | $0.68 | $68K |
| Nov 30, 2022 | Jin David | Chief Financial Officer | Buy(P) | 5K | $0.56 | $3K |
| Nov 30, 2022 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Buy(P) | 5K | $0.56 | $3K |
| Oct 26, 2022 | Jin David | Chief Financial Officer | Grant(A) | 1.4M | — | $0 |
| Oct 21, 2022 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Buy(P) | 100K | $0.70 | $70K |
| Jun 1, 2022 | Rosenwald Lindsay A MD | President, CEO & Chairman, Director, 10% Owner | Grant(A) | 4K | $0.73 | $3K |
| Jan 1, 2022 | Klein Dov | Director | Grant(A) | 100K | — | $0 |
| Jan 1, 2022 | Weiss Michael S | See Remarks, Director, 10% Owner | Grant(A) | 1.1M | — | $0 |
| Jan 1, 2022 | Hoenlein Malcolm | Director | Grant(A) | 50K | — | $0 |
| Jan 1, 2022 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Grant(A) | 1.1M | — | $0 |
| Jan 1, 2022 | Lorenz Kevin | Director | Grant(A) | 50K | — | $0 |
| Jan 1, 2022 | Harvey Jimmie | Director | Grant(A) | 100K | — | $0 |
| Jan 1, 2022 | Lobell J Jay | Director | Grant(A) | 100K | — | $0 |
| Jan 1, 2022 | Rowinsky Eric K | Director | Grant(A) | 100K | — | $0 |
| Dec 28, 2021 | Klein Dov | Director | Sell(S) | 5K | $2.45 | $12K |
| Dec 1, 2021 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Grant(A) | 1K | $2.42 | $3K |
| Nov 16, 2021 | Klein Dov | Director | Other(J) | 230 | — | $0 |
| Nov 16, 2021 | Hoenlein Malcolm | Director | Other(J) | 230 | — | $0 |
| Nov 16, 2021 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Other(J) | 5K | — | $0 |
| Sep 30, 2021 | Klein Dov | Director | Other(J) | 480 | — | $0 |
| Sep 30, 2021 | Hoenlein Malcolm | Director | Other(J) | 406 | — | $0 |
| Sep 30, 2021 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Other(J) | 8K | — | $0 |
| Sep 21, 2021 | Hunter Robyn | Chief Financial Officer | Sell(S) | 28K | $3.13 | $89K |
| Aug 5, 2021 | Klein Dov | Director | Other(J) | 305 | — | $0 |
| Jun 1, 2021 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Grant(A) | 1K | $2.31 | $3K |
| Mar 2, 2021 | Rowinsky Eric K | Director | Sell(S) | 10K | $4.45 | $45K |
| Feb 19, 2021 | Rowinsky Eric K | Director | Sell(S) | 8K | $4.31 | $34K |
| Feb 18, 2021 | Rowinsky Eric K | Director | Sell(S) | 6K | $4.20 | $25K |
| Feb 16, 2021 | Rowinsky Eric K | Director | Sell(S) | 2K | $3.86 | $8K |
| Feb 5, 2021 | Rowinsky Eric K | Director | Sell(S) | 4K | $3.80 | $15K |
| Jan 1, 2021 | Weiss Michael S | See Remarks, Director, 10% Owner | Grant(A) | 1.0M | — | $0 |
| Jan 1, 2021 | Rowinsky Eric K | Director | Grant(A) | 100K | — | $0 |
| Jan 1, 2021 | Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN, Director, 10% Owner | Grant(A) | 1.0M | — | $0 |
| Jan 1, 2021 | Lorenz Kevin | Director | Buy(P) | 50K | — | $0 |
| Jan 1, 2021 | Lobell J Jay | Director | Grant(A) | 100K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).